INVICTUS

INVICTUS (TB-500/KPV/Thymosin Alpha-1 Blend)

Chemical Information:

• Composition: Three-component synthetic peptide blend — TB-500 (10 mg) / KPV (10 mg) / Thymosin Alpha-1 (5 mg)
• TB-500 (Thymosin β4, TB4):
  • Molecular Formula: C₂₁₂H₃₅₀N₅₆O₇₈S
  • Molecular Weight: ~4963.4 g/mol
  • Sequence: Ac-Ser-Asp-Lys-Pro-Asp-Met-Ala-Glu-Ile-Glu-Lys-Phe-Asp-Lys-Ser-Lys-Leu-Lys-Lys-Thr-Glu-Thr-Gln-Glu-Lys-Asn-Pro-Leu-Pro-Ser-Lys-Glu-Thr-Ile-Glu-Gln-Glu-Lys-Gln-Ala-Gly-Glu-Ser (43-mer)
• KPV:
  • Molecular Formula: C₁₆H₃₀N₄O₄
  • Molecular Weight: ~342.43 g/mol
  • Sequence: Lys-Pro-Val
• Thymosin Alpha-1:
  • Molecular Formula: C₁₂₉H₂₁₅N₃₃O₅₅
  • Molecular Weight: ~3108.28 g/mol
  • Sequence: Ac-Ser-Asp-Ala-Ala-Val-Asp-Thr-Ser-Ser-Glu-Ile-Thr-Lys-Phe-Ile-Glu-Gly-Gln-Asp-Ser-Ala-Lys-Glu-Gln-Glu-Val-Val-Glu-Ala-Glu-Asn-OH
• Structure Class: Synthetic multi-peptide research blend

Product Description:

The INVICTUS Blend is a research formulation consisting of three structurally defined synthetic peptide components: TB-500 (Thymosin β4, full-length), KPV, and Thymosin Alpha-1. Each component is produced through controlled solid-phase peptide synthesis (SPPS) and combined in a standardized formulation for use in laboratory research environments. This product is a research-grade reagent; Thymosin Alpha-1 included in this blend is not manufactured under GMP conditions and is not equivalent to, or a substitute for, any approved pharmaceutical product. This blend is utilized in controlled experimental settings for analytical evaluation of peptide behavior, stability, and interaction within defined systems. All applications are limited to in vitro research models. The product is supplied in lyophilized powder form to support stability and integrity during storage and handling. This product is not formulated for clinical, diagnostic, or therapeutic use.

Research Applications:

• Analytical evaluation of peptide structure and composition within multi-component systems
• Examination of stability and degradation profiles of combined peptide formulations
• Investigation of peptide behavior in biochemical and in vitro assay environments
• Characterization of interactions between peptide components under controlled experimental conditions

Storage and Handling:

• Store lyophilized material at -20 °C for long-term stability
• Reconstituted solutions should be stored at 2–8 °C and used promptly
• Protect from light, heat, and repeated freeze–thaw cycles
• Handle using appropriate laboratory safety and aseptic techniques

Product Specifications:

• Composition: 10 mg TB-500 (Thymosin β4, full-length) / 10 mg KPV / 5 mg Thymosin Alpha-1 (refer to lot-specific Certificate of Analysis)
• Purity: ≥99% per component (HPLC Certified)
• Appearance: White to off-white lyophilized powder
• Solubility: Soluble in suitable laboratory agents
• Form: Lyophilized powder

Compliance Notice:

INVICTUS (TB-500/KPV/Thymosin Alpha-1 Blend) is FOR RESEARCH USE ONLY. It is not intended for human or veterinary use. This product has not been evaluated by the FDA. Misuse of this product is strictly prohibited and may violate federal, state, or local laws. By purchasing this product, buyer represents and warrants that it will be used only for in vitro research purposes.